早期诊断帕金森病的生物标志物

F. Yusupov, A. Yuldashev, T. Nurmatov
{"title":"早期诊断帕金森病的生物标志物","authors":"F. Yusupov, A. Yuldashev, T. Nurmatov","doi":"10.33619/2414-2948/104/33","DOIUrl":null,"url":null,"abstract":"The World Health Organization (WHO) has stated that neurodegenerative diseases will be the biggest health problem in the future. Among neurodegenerative diseases, Parkinson’s disease is the second most common after Alzheimer’s disease. Parkinson’s disease (PD) is the most common pathology of a person with movement disorders. Among neurological diseases, it has a high social significance due to the negative effect on the quality of life (early loss of the ability to work, progressive disorders of motor and cognitive skills). With increasing life expectancy, the prevalence of Parkinson’s disease increases. Biological markers of early diagnosis of Parkinson’s disease are being actively studied. The review presents the most clinically significant biological markers for the preclinical diagnosis of Parkinson’s disease. Biomarkers of cerebrospinal fluid, serum biomarkers and biomarkers of other biological fluids in Parkinson's disease are discussed.","PeriodicalId":505704,"journal":{"name":"Bulletin of Science and Practice","volume":"69 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biomarkers of Early Diagnosis of Parkinson’s Disease\",\"authors\":\"F. Yusupov, A. Yuldashev, T. Nurmatov\",\"doi\":\"10.33619/2414-2948/104/33\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The World Health Organization (WHO) has stated that neurodegenerative diseases will be the biggest health problem in the future. Among neurodegenerative diseases, Parkinson’s disease is the second most common after Alzheimer’s disease. Parkinson’s disease (PD) is the most common pathology of a person with movement disorders. Among neurological diseases, it has a high social significance due to the negative effect on the quality of life (early loss of the ability to work, progressive disorders of motor and cognitive skills). With increasing life expectancy, the prevalence of Parkinson’s disease increases. Biological markers of early diagnosis of Parkinson’s disease are being actively studied. The review presents the most clinically significant biological markers for the preclinical diagnosis of Parkinson’s disease. Biomarkers of cerebrospinal fluid, serum biomarkers and biomarkers of other biological fluids in Parkinson's disease are discussed.\",\"PeriodicalId\":505704,\"journal\":{\"name\":\"Bulletin of Science and Practice\",\"volume\":\"69 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of Science and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33619/2414-2948/104/33\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33619/2414-2948/104/33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

世界卫生组织(WHO)指出,神经退行性疾病将是未来最大的健康问题。在神经退行性疾病中,帕金森病是仅次于阿尔茨海默病的第二大常见疾病。帕金森病(Parkinson's disease,PD)是运动障碍患者最常见的病症。在神经系统疾病中,帕金森病具有很高的社会意义,因为它会对患者的生活质量产生负面影响(早期丧失工作能力、进行性运动和认知能力障碍)。随着预期寿命的延长,帕金森病的发病率也在增加。目前正在积极研究早期诊断帕金森病的生物标志物。本综述介绍了对临床前诊断帕金森病最有临床意义的生物标志物。文中讨论了帕金森病的脑脊液生物标志物、血清生物标志物和其他生物液体的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Biomarkers of Early Diagnosis of Parkinson’s Disease
The World Health Organization (WHO) has stated that neurodegenerative diseases will be the biggest health problem in the future. Among neurodegenerative diseases, Parkinson’s disease is the second most common after Alzheimer’s disease. Parkinson’s disease (PD) is the most common pathology of a person with movement disorders. Among neurological diseases, it has a high social significance due to the negative effect on the quality of life (early loss of the ability to work, progressive disorders of motor and cognitive skills). With increasing life expectancy, the prevalence of Parkinson’s disease increases. Biological markers of early diagnosis of Parkinson’s disease are being actively studied. The review presents the most clinically significant biological markers for the preclinical diagnosis of Parkinson’s disease. Biomarkers of cerebrospinal fluid, serum biomarkers and biomarkers of other biological fluids in Parkinson's disease are discussed.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信